Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases
Abstract The WHO classifications of 2017 and 2022 recommend the use of pituitary transcription factors PIT-1, T-PIT and SF-1 as well as GATA3 and ERα for histopathological diagnosis. The aim of this study is to demonstrate their diagnostic impact in a large retrospective cohort. 921 PitNETs/PAs diag...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2025-06-01
|
| סדרה: | Acta Neuropathologica Communications |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s40478-025-02050-8 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
